This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, C. Articles by Jones, C. Search for Related Content PubMed PubMed Citation Articles by Huang, C. Articles by Jones, C.

Repression of Protein Kinase C and Stimulation of Cyclic AMP Response Elements by Fumonisin, a Fungal Encoded Toxin Which Is a Carcinogen¹

Department of Plant Pathology [C. H., M. D.], Center for Biotechnology [G. H., C. J.], and Department of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583

Fusarium moniliforme (FM) is a major fungal pathogen of corn and is involved with stalk rot disease. FM is widely spread throughout the world, including the United States. Most strains of FM produce several mycotoxins, the most prominent of which is called fumonisin. Recent epidemiological studies indicated that ingestion of fumonisin correlates with a higher incidence of esophageal cancer in Southern and Northern Africa and China. Furthermore, fumonisin causes a neurodegenerative disease in horses, induces hepatic cancer in rats, and induces pulmonary edema in swine. Considering that high levels of fumonisin have been detected in healthy and diseased corn grown in the United States, fumonisin may pose a health threat to humans and livestock animals. Structurally, fumonisin resembles sphingolipids which are present in the membranes of animal and plant cells. At the present time, very little is known concerning the mechanism by which fumonisin elicits its carcinogenic effect. Our studies indicate that fumonisin represses expression of protein kinase C and AP-1-dependent transcription. In contrast, fumonisin stimulated a simple promoter containing a single cyclic AMP response element. Since fumonisin did not alter protein kinase A activity, it appears that cyclic AMP response element activation was independent of protein kinase A. It is hypothesized that the ability of fumonisin to alter signal transduction pathways plays a role in carcinogenesis.

¹ This study was supported by a grant from the Institute of Agriculture and Natural Resources (University of Nebraska-Lincoln) and the Center for Biotechnology.

² To whom requests for reprints should be addressed, at Department of Veterinary and Biomedical Sciences, University of Nebraska Lincoln, P.O. Box 830905, Lincoln, NE 66583-0905.

Received 1/18/95. Accepted 3/ 3/95.

This article has been cited by other articles:

				D. Ramljak, R. J. Calvert, P. W. Wiesenfeld, B. A. Diwan, B. Catipovic, W. F.O. Marasas, T. C. Victor, L. M. Anderson, and W. C.A. Gelderblom A potential mechanism for fumonisin B1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3{beta} activity Carcinogenesis, August 1, 2000; 21(8): 1537 - 1546. [Abstract] [Full Text] [PDF]

				Y. Zhang, M. B. Dickman, and C. Jones The Mycotoxin Fumonisin B1 Transcriptionally Activates the p21 Promoter through a cis-Acting Element Containing Two Sp1 Binding Sites J. Biol. Chem., April 30, 1999; 274(18): 12367 - 12371. [Abstract] [Full Text] [PDF]

				R. R. Dugyala, R. P. Sharma, M. Tsunoda, and R. T. Riley Tumor Necrosis Factor-alpha as a Contributor in Fumonisin B1 Toxicity J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 317 - 324. [Abstract] [Full Text]

				E. R. Smith, P. L. Jones, J. M. Boss, and A. H. Merrill Jr. Changing J774A.1 Cells to New Medium Perturbs Multiple Signaling Pathways, Including the Modulation of Protein Kinase C by Endogenous Sphingoid Bases J. Biol. Chem., February 28, 1997; 272(9): 5640 - 5646. [Abstract] [Full Text] [PDF]

				W. D. Jarvis, F. A. Fornari Jr., R. S. Traylor, H. A. Martin, L. B. Kramer, R. K. Erukulla, R. Bittman, and S. Grant Induction of Apoptosis and Potentiation of Ceramide-mediated Cytotoxicity by Sphingoid Bases in Human Myeloid Leukemia Cells J. Biol. Chem., April 5, 1996; 271(14): 8275 - 8284. [Abstract] [Full Text] [PDF]